Ashraf B Abdel-Naim Selected Research

Ashraf B Abdel-Naim Research Topics

Disease

16	Neoplasms (Cancer) 01/2021 - 10/2008
8	Inflammation (Inflammations) 12/2022 - 02/2005
8	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2022 - 05/2013
7	Wounds and Injuries (Trauma) 12/2022 - 04/2011
6	Body Weight (Weight, Body) 11/2020 - 05/2013
6	Edema (Dropsy) 01/2020 - 03/2012
5	Cardiotoxicity 02/2022 - 05/2010
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 04/2016
5	Breast Neoplasms (Breast Cancer) 07/2015 - 09/2005
4	Hyperplasia 08/2022 - 12/2014
4	Necrosis 12/2021 - 04/2009
4	Prostatic Neoplasms (Prostate Cancer) 07/2018 - 08/2013
4	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 01/2009
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2022 - 09/2020
3	Hypoxia (Hypoxemia) 01/2022 - 12/2014
3	Insulin Resistance 01/2021 - 09/2020
3	Colonic Neoplasms (Colon Cancer) 07/2020 - 04/2020
3	Liver Neoplasms (Liver Cancer) 06/2020 - 10/2013
3	Osteoporosis 12/2019 - 01/2014
3	Fibrosis (Cirrhosis) 01/2019 - 01/2013
2	Bone Resorption 07/2020 - 01/2014
2	Carcinoma (Carcinomatosis) 01/2017 - 06/2014
2	Rheumatoid Arthritis 01/2014 - 10/2010
2	Experimental Arthritis 01/2014 - 10/2010
2	Arthritis (Polyarthritis) 01/2014 - 10/2010
1	Obesity 05/2022
1	Endometrial Hyperplasia 04/2022
1	Heart Injuries 02/2022
1	Ulcer 12/2021
1	Oral Ulcer (Mouth Ulcer) 12/2021

Drug/Important Bio-Agent (IBA)

10	Testosterone (Sustanon)FDA Link 11/2021 - 05/2013
8	2-MethoxyestradiolIBA 08/2022 - 10/2008
8	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 10/2008
8	AntioxidantsIBA 02/2022 - 04/2011
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 02/2005
7	CarrageenanIBA 01/2020 - 03/2012
4	Interleukin-6 (Interleukin 6)IBA 12/2022 - 10/2012
4	icariinIBA 03/2022 - 08/2017
4	Estrogens (Estrogen)FDA Link 12/2019 - 09/2005
4	EnzymesIBA 07/2018 - 07/2012
4	ProstaglandinsIBA 01/2014 - 04/2009
4	Dinoprostone (PGE2)FDA Link 01/2014 - 01/2012
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013 - 02/2005
3	NanoconjugatesIBA 12/2022 - 10/2021
3	Melitten (Melittin)IBA 12/2022 - 10/2021
3	CollagenIBA 05/2022 - 12/2014
3	3,3',4,5'-tetrahydroxystilbeneIBA 04/2022 - 01/2020
3	Estradiol (Delestrogen)FDA LinkGeneric 04/2022 - 01/2009
3	Glutathione (Reduced Glutathione)IBA 03/2022 - 01/2013
3	Pharmaceutical PreparationsIBA 11/2017 - 10/2010
3	3,4-dihydroxybenzohydroxamic acidIBA 11/2016 - 10/2013
3	Methotrexate (Mexate)FDA LinkGeneric 10/2016 - 10/2010
3	Peroxidase (Myeloperoxidase)IBA 01/2014 - 01/2012
2	HydrogelsIBA 12/2022 - 10/2021
2	FatsIBA 05/2022 - 01/2021
2	CatalaseIBA 03/2022 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 10/2016
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2008
2	Hydroxyproline (4 Hydroxyproline)IBA 10/2021 - 01/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2020 - 11/2019
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2019 - 09/2016
2	AndrogensIBA 07/2018 - 05/2013
2	catechol (pyrocatechol)IBA 07/2018 - 07/2012
2	Acid PhosphataseIBA 01/2018 - 01/2014
2	Sorafenib (BAY 43-9006)FDA Link 11/2017 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2017 - 06/2014
2	Sunitinib (Sutent)FDA Link 01/2017 - 06/2014
2	Chloroform (Trichloromethane)IBA 01/2017 - 01/2015
2	ResveratrolIBA 11/2016 - 07/2015
2	caffeic acid phenethyl esterIBA 10/2016 - 08/2013
2	Docetaxel (Taxotere)FDA Link 01/2016 - 08/2013
2	Superoxide DismutaseIBA 01/2015 - 01/2013
2	1-Butanol (n Butanol)IBA 01/2015 - 06/2013
2	SilymarinIBA 12/2014 - 05/2013
2	Collagen Type II (Type II Collagen)IBA 01/2014 - 10/2010
2	nimesulide (Aulin)IBA 01/2014 - 10/2010
2	Estrogen ReceptorsIBA 08/2013 - 07/2013
2	Croton OilIBA 10/2012 - 03/2012
2	LipopolysaccharidesIBA 10/2012 - 02/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2011 - 05/2010
2	Tamoxifen FDA LinkGeneric 07/2009 - 09/2005
1	Glatiramer Acetate (Copaxone)FDA Link 12/2022
1	Gabapentin (Neurontin)FDA LinkGeneric 12/2022
1	Thioctic Acid (Lipoic Acid)IBA 12/2022
1	Streptozocin (Streptozotocin)FDA Link 05/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2022
1	AnthracyclinesIBA 02/2022
1	MB Form Creatine KinaseIBA 02/2022
1	mokko lactoneIBA 02/2022
1	TroponinIBA 02/2022
1	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2022
1	Diclofenac (SR 38)FDA LinkGeneric 01/2022
1	ethyl acetateIBA 12/2021
1	Acetic Acid (Vinegar)FDA LinkGeneric 12/2021
1	auraptenIBA 11/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 10/2021

Therapy/Procedure

7	Therapeutics 11/2017 - 10/2008
2	Radiotherapy 01/2015 - 10/2013